What is the current Global Active Pharmaceutical Ingredients CDMO Market size?

In 2024, the Global Active Pharmaceutical Ingredients CDMO Market size is expected to reach USD 118.09 billion. Read More

Who are the key players in Global Active Pharmaceutical Ingredients CDMO Market?

Catalent, Inc., Cambrex Corporation, Lonza Group, Recipharm AB and Astorg (Corden Pharma) are the major companies operating in the Global Active Pharmaceutical Ingredients CDMO Market. Read More

Which is the fastest growing region in Global Active Pharmaceutical Ingredients CDMO Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Active Pharmaceutical Ingredients CDMO Market?

In 2024, the Asia-Pacific accounts for the largest market share in Global Active Pharmaceutical Ingredients CDMO Market. Read More

What years does this Global Active Pharmaceutical Ingredients CDMO Market cover, and what was the market size in 2023?

In 2023, the Global Active Pharmaceutical Ingredients CDMO Market size was estimated at USD 107.92 billion. The report covers the Global Active Pharmaceutical Ingredients CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Active Pharmaceutical Ingredients CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Active Pharmaceutical Ingredients CDMO Companies

Q: How big is the Global Active Pharmaceutical Ingredients CDMO Market?

The Global Active Pharmaceutical Ingredients CDMO Market size is expected to reach USD 118.09 billion in 2024 and grow at a CAGR of 8.61% to reach USD 178.47 billion by 2029. Read More

This report lists the top Global Active Pharmaceutical Ingredients CDMO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Active Pharmaceutical Ingredients CDMO industry.